Washington Dulles International Airport (IAD) and Brussels Airport (BRU) have signed a memorandum of understanding with United Airlines to establish a dedicated transatlantic super-corridor for pharmaceutical and life science products. The agreement standardizes processes and streamlines logistics, positioning Dulles as the East Coast gateway for biopharma cargo from Europe’s manufacturing hotspots in Belgium and Virginia.
United Airlines, operating its passenger hub at Dulles since 1986, will serve as the primary carrier on the route. The partnership addresses fragmented point-to-point shipping by creating reliable pathways for raw materials and finished medicines, easing pressure on European facilities and other U.S. airports.
Virginia Economic Development Partnership (VEDP) facilitated the deal to spur biopharma manufacturing growth in the Commonwealth. Brussels Airport, a proven European pharma cargo hub, brings established expertise to optimize procedures and incentivize shippers, freight forwarders, and pharma companies.
This corridor enhances supply chain efficiency amid global pharma trade tensions, including U.S. tariff policies. It supports operational scalability for U.S.-Europe biopharma exchanges, driving investment and manufacturing expansions at Dulles.